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Single kidney function: Early and tate changes in urate transport after
nephrectomy. Renal urate transport was studied by means of pyrazina-
mide (PZA) and probenecid (PB): (a) before and at 2, 6, 24 weeks (24
patients), (b) I to 30 years after uninephrectomy in 27 and 12 patients
with Cr > 80 and 30 to 70 mI/mm, respectively. Uninephrectomy was
followed by important tubular urate transport modifications during at
least two weeks, which lead to a marked uricosuria as indicated by
significant increase in FE (mean value so, 0.228 0.059 vs. 0.097
0.014 and 0.099 0.019 in normals and chronically diseased solitary
kidneys). Reduced response to PZA and PB suggests a diminished
reabsorptive capacity for urate mainly at the presecretory site which
persisted after FENa normalization. Tubular compensations were pre-
sumably complete at six weeks, since pattern of urate transport
returned to normal with an almost complete reabsorption of filtered
urate load (99%) and a percentage of postsecretory reabsorption (80%)
very close to those seen in normal subjects with a pair of kidneys. The
adjustment in urate excretion in solitary kidneys was achieved by a
significant increase of secreted urate as compared with 50% of pre-
uninephrectomy values. Thus, increased urate secretion by the remain-
ing intact organ is sufficient to maintain urate balance with a normal
serum level.
Unilateral nephrectomy was thought to be without significant
adverse long-term sequelae because patients reported have had
normal life expectancies [1—6]. However, renal ablation results
in progressive renal failure and advanced glomerulosclerosis in
animal models 17—91, raising concern that the patient having a
unilateral nephrectomy may be at risk for significant morbidity
and perhaps mortality as a result of the effects that removal of
one kidney may have on residual renal function [8, 10—141. The
issue has focused in particular on kidney donors who may be at
risk for long-term renal dysfunction as a result of elective
donation. Thus, considerable controversy has been generated
about the continuation of kidney transplantation programs that
involve living related donors [15—20].
Hyperuricemia and increased fractional urate excretion have
recently been reported in patients with solitary kidneys, and it
is thought that these factors might be harmful to the structure
and function of the remaining kidney [12]. However, the
association of hypertension and renal failure in a high incidence
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in these patients suggests that hyperuricemia might reflect
rather than contribute to renal vascular and functional impair-
ment [21, 22].
In 1975, Pabico, McKenna and Freeman reported an in-
creased fractional urate excretion immediately after unilateral
nephrectomy, which could not be attributed solely to the rise in
GFR of the remaining kidney [23]. A rise in GFR requires a
commensurate increase in the ability of the tubular system to
deal with the filtrate if normal renal physiology is to be
maintained. It is believed that the restoration of "glomerulotu-
bular balance" necessitates hypertrophy and hyperplasia of
tubule cells, but functional aspects of such tubular changes in
urate transport after uninephrectomy are not known. To our
knowledge, studies on renal tubular urate transport mecha-
nisms in subjects undergoing uninephrectomy are lacking in the
literature.
Therefore, in a relative large number of patients and at
different time intervals after uninephrectomy, we studied early
and late changes in tubular urate transport by means of proben-
ecid (PB) and pyrazinamide (PZA) tests. The response of urate
excretion to these drugs has been widely used to analyze the
tubular mechanisms of urate transport in normal subjects and in
patients with abnormal urate clearance [22, 24—34].
Methods
Patients
Four groups of patients with solitary kidneys were studied.
Group A consisted of nine patients (males, aged between 38 and
73 years). These underwent unilateral nephrectomy for adeno-
carcinoma. Renal function was monitored before, within two
weeks, and six as well as 24 weeks after nephrectomy.
Group B consisted of 15 patients (14 males and 1 female, aged
between 33 and 75 years) who were investigated before and 24
weeks after unilateral nephrectomy for the following reasons:
adenocarcinoma in Ii, kidney donation in two, and nephroli-
thiasis in two patients.
Group C consisted of 27 single kidney patients (18 males,
aged between 22 and 65 years; 9 females aged between 36 and
64 years). They were selected among a large group of patients
with solitary kidneys according to the following criteria: a)
nephrectomy performed one or more years ago; b) no evidence
of systemic disease processes which might have affected the
contralateral kidney; c) normal function of remaining kidney; d)
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Table 1. Renal function and urate excretion before and after uninephrectomy
Group A (N 9) Group B (N = 15)
Before (a)
After weeks
Before
(a!)
After 24
weeks
(bI)2 (b) 6 (c) 24 (d)
Scr mg/dl 1.14 0.16 1.73 0.27 1.34 0.16 1.29 0.15 1.16 0.12 1.31 0.15
t-test,P a—b<O.001 a—c<0.01 a—d=NS al—bl=NS
F-test P = NS
Ccr mI/mm 104.48 16.72 65.35 13.6 89.53 11.44 95.71 10.20 92.76 14.48 86.67 8.98
i-test,P a—bcO.001 a—c<0.01 a—d<0.01 al—blczo.01
F-test P = NS
ur mg/dI 4.63 0.92 4.79 1.03 4.72 0.89 4.62 0.90 4.95 1.21 4.82 0.90
t-test,P a—b=NS a—c=NS a—d=NS al—bl=NS
F-test P = NS
Cur mI/rn/n 10.24 2.18 15.39 6.03 8.77 1.88 9.02 1.96 10.08 2.24 9.73 1.92
i-test,P a—b=NS a—c=NS a—d=NS aI—bl =NS al—c=NSb—c=NS b—d=NS al—d=NS
F-test P = NS
Eur ,ug/rnin 464 123 695 172 409 100 451 102 482 108 484 91
t-test,P a—b<0.005 a—c=NS a—d=NS al —b1NS
F-test P = NS
Fur jig/rn/n 5005 915 3061 624 4196 806 4032 785 4470 904 4321 868
i-test,P a—b<0.001 a—c=NS a—d=NS aI—bl=NS
F-test P = NS
(CutiCcr) 0.097 0.014 0.228 0.059 0.097 0.014 0.103 0.016 0.102 0.020 0.112 0.0234
FEur
i-test,P a—b<0.001 a—c=NS a—d=NS al—bl=NS
b—c<0.00l b—d<0.001
F-test P C 0.05
Data are presented as mean sn. Abbreviations are: Sf1, serum creatinine; Ccr, clearance creatinine; Fur, filtered urate; fur' plasma urate; Cur,
clearance urate; Eur, excreted urate.
normal arterial pressure. Among the subjects two had unilateral
renal agenesis, five were living-related transplant donors and
the remainder had undergone nephrectomy for unilateral renal
disease [nephrolithiasis (4), ureteropelvic junction stenosis (3),
hydronephrosis (2), renal cysts (3), and renal trauma (I)],
Patients with single kidneys ranged in age from 1 to 30 years
(mean SD = 11.44 9.95) with the assumption that patients
with renal agenesis had a single kidney from birth. All patients
had a normal serum creatinine and creatinine clearance. This
group was compared with 21 healthy subjects who were age and
sex matched.
Group D consisted of 12 patients [8 males and 4 females, aged
from 30 to 75 years with chronic renal insufficiency (CR1), Ccr
= 30 to 70 ml/min] in whom the interval between nephrectomy
and renal function studies exceeded one year (range from 3 to
18 years). Nephrectomy was performed because of staghorn
calculus [7] or hydronephrosis [5].
Patients with gouty nephropathy, a past history or a history
of gout or any disease known to affect urate excretion were
excluded. Furthermore, none of the patients was receiving
diuretics or any other drug affecting urate excretion for at least
two weeks before the investigation.
The study protocol had been approved by the medical ethics
committee. In group A, after surgical procedure, patients daily
received intravenously two liters of 5% dextrose supplemented
with one liter of normal saline. On the third day infusions were
stopped and oral nutrition was progressively reintroduced. PB
and PZA tests were performed 7 and 11 days after the surgery.
The study started in the morning after an overnight fast;
breakfast was omitted. PB and PZA tests were performed
according to the protocols previously described [22, 24—34].
Standard clearance techniques were employed. Each test con-
sisted of two phases: one before (control phase) and the other
after drug administration (PB 2 g orally or PZA 3 g orally in a
single dose). The control phase of each test involved two or
three 45-minute clearance periods. Urine was collected for four
additional clearance periods. The first clearance period after
PZA administration started after a 60 minute delay.
Urate concentrations both in urine and plasma were mea-
sured using a unease method. Urine and serum ereatinine
concentrations were determined enzymatically (determination
of real creatinine).
The values for plasma urate, urate clearance, FEur, as well as
the values for filtered and excreted urate, represent averages of
the control clearance periods in PB and PZA tests. Patients with
a deviation of more than 10% between any reproduced mea-
surement were excluded.
Results
Table 1 summarizes the pre- and post-uninephrectomy values
for renal function and renal urate excretion. FEur initially was
increased, but returned to normal 6, as well as 24 weeks after.
In group B patients data also were similar.
Table 2 represents data from studies on renal urate transport
using PZA and PB tests before and after uninephrectomy.
Response to PZA was significantly impaired two weeks after
surgery: (a) PZA-nonsuppressible urate was significantly higher
compared with pre-operative values either expressed as abso-
lute amount, or per 100 ml GFR. (b) Also, FEur after PZA was
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Table 2. Data from PZA and PB tests before and after uninephrectomy (mean SD)
A(9) B(15)
After nephrectoniy After
nephrectomy
Before (2) weeks (6) weeks F-test t-test Before 24 weeks
Group (a) (b) (c) P P (al)a (bI)
PZA-suppressible urate 435 125 555 164 373 105 NS a — b = NS 438 74 462 37
p.g/min a—c=NS
PZA-suppressible urate 422 118 838 162 417 104 <.01 a — b < 0.001 441 76 533 46
pg/min/1OO ml GFR a — c = NS
PZA-nonsuppressible 28 14 139 30 35 13 <0.01 a — b <0.001 42 11 48 11
urate /.tg/min a — c = NS
PZA-nonsuppressible 27 15 223 70 40 16 <0.05 a — b <0.001 42 11 55 14
urate p.g/min/100 ml a — c = NS
GFR
PZA-nonsuppressible 6.60 4.39 26.94 6.74 9.35 4.35 NS a — b <0.001 8.71 11.36
urate % of Es,. a — c = NS
FE0r after PZA 0.005 0.003 0.050 0.016 0.007 0.003 <0.05 a — b < 0.001 0.008 0.003 0.009 0.003
a — c = NS
Reabsorption of Fur 4977 919 2921 622 4160 804 NS a — b <0.001 4428 912 4272 876
g/min a—c=NS
% Reabsorption Of Fur 99.39 0.34 93.86 1.87 99.13 0.35 <0.01 a — b <0.001 99.06 0.33 98.86 0.41
a — c = NS
FEur after PB 0.326 0.047 0.243 0.072 0.307 0.053 NS a — b < 0.01 0.317 0.046 0.289 0.063
a — c = NS
Reabsorption Of Sur 1374 289 965 170 1312 212 NS a — b <0.001 1293 300 1397 224
jrg/min a—c=NS
Sur p.g/min 1810 355 1519 319 1619 269 NS a — b = NS 1731 288 1864 241
a — c = NS
Abbreviations are: PZA, pyrazinamide; PB, probenecid; Fur, filtered urate; Su, secreted urate; Eur, excreted urate; FEur, CurlCcr, FE=.,
change of FEur or response to PB.
P = NS for all al — bi comparisons
Table 3. Fractional excretion of sodium (FENa) and urate (FEur) after uninephrectomy
FENa FEur
Before After nephrectomy days Before After nephrectomy days
(a) 2(b) 5(c) 7(d) 10(e) (a) 2(b) 5(c) 7(d) 10(e)
Mean SD 0.823 3.06 1.94 1.33 0.92 0.097 0.259 0.232 0.223 0.210
0.202 0.416 0.269 0.259 0.148 0.014 0.053 0.056 0.069 0.043
t-test,P a—b<0.001 a—c<0.001 a—b<0.001 a—c<0.001
a—d<0.01 a—e=NS a—d<0.OOl a—e<0.001
F-test P < 0.00001 P = NS
significantly higher. The percentage of reabsorption of filtered
urate was 93.86% versus 99.39% pre-operatively.
PZA-suppressible urate, in absolute values, did not differ
significantly two weeks after surgery; however when it was
expressed per 100 ml GFR it was higher post-operatively.
Maximal uricosuric response to PB was impaired after unine-
phrectomy. Finally, secreted urate did not show significant
difference pre- and post-operatively. All the above parameters
returned to normal 6 and 24 weeks after uninephrectomy.
Table 3 represents correlation between FENa and FEur im-
mediately after uninephrectomy.
Table 4 presents comparisons between group A (patients with
acutely reduced GFR two weeks after uninephrectomy) and
group D patients [uninephrectomized year(s) before and with
chronically diseased single kidney and diminished GFR]. In
group A patients Cur and FEur were significantly higher com-
pared with values of group D patients. These findings suggest a
Table 4. Renal function and urate excretion in patients with GFR 30
to 70 mI/mm (mean SD)
After After
nephrectomy nephrectomy
(2 weeks) (>1 year)
Groups (a)a (b)' p
N 9 12
Scr mg/dl 1.73 0.27 1.75 0.55 a — b = NS
Ccr mI/mm 65.35 13.6 52.95 11.88 a — b = NS
Pumg/dl 4.79 1.03 6.15 0.85 a — b <0.01
Cur mI/mm 15.39 6.03 5.29 1.62 a — b < 0.001
Eur g/min 695 172 317 76 a — b <0.001
Fur ag/min 3061 624 3237 751 a — b = NS
FEur (Cur/Ccr) 0.228 0.059 0.099 0.019 a — b <0.001
Abbreviations are: Sr, serum creatinine; Car, clearance creatinine;
ur, plasma urate; Cu, clearance urate; Ear, excreted urate; Fur, filtered
urate.
a Group A patientsb
Group D patients
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Table 5. Data from PZA and PB tests in patients with GFR 30 to 70 mi/mm (mean su)
After
nephrectomy
(2 weeks)
(a)a
9
555 164
(838 162)C139 30
(223 70)
0.050 0.016
2921 622
(4567 1005)
93.86 1.87
965 170
(1482 258)
0.243 0.072
1519 319
(2337 335)
After
nephrectomy
(>1 year)
(b)"
12
274 88
(515 108)
43 35
(87 71)
0.015 0.012
3194 749
(6069 832)
98.67 0.34
738 112
(1431 236)
0.261 0,043
1012 192
(1947 289)
a — b <0.001
a — b < 0.001
a — b <0.001
a — b NS
a — b <0.01
a — b = NS
a — b = NS
a — b = NS
Table 6. Renal urate excretion in solitary kidneys with GFR > 80 mI/mm/I .73 m2 (mean SD)
sCr
mgldl
cCr
mi/mm
pur
mg/dl
cur
mi/mm
Eur F. cC01] Cr
(FEur)/.tg/min
Group C
>1 year after 1.17 0.13 90.16 12.00 5.08 1.03 8.99 2.76 446 134 4573 1037 0.098 0.023
nephrectomy
(a) (N = 27)
Controls
(b) (N = 21) 0.97 0.22 101.62 15.26 4.67 1.20 9.53 2.11 437 129 4712 1217 0.093 0.018
P NS <0.01 NS NS NS NS NS
Abbreviations are: Sr, serum creatinine; 11ur' plasma urate; Eur, excreted orate; Car, clearance creatimne; Cur, clearance urate; F0, filtered
Urate.
"state of uricosuria" during two weeks following uninephrec-
tomy (higher than expected for the Ce,, value and compared
with chronically reduced GFR).
Presecretory reabsorbed urate was higher while secreted
urate per 100 ml GFR was lower in chronically diseased kidney,
suggesting a diminished capacity of tubular secretion. The
increase of FEur after PB was similar (Table 5).
The pattern of renal urate transport in solitary kidney with
normal renal function appears to be similar to those of controls
with a pair of kidneys (Tables 6 and 7, Fig. 1).
Discussion
After a decrease in glomerular filtration rate secondary to
kidney removal, the glomerular adaptation phenomenon was
characterized by an increase from 62.54% (two weeks) to
85.69% (six weeks), and 93.43% (24 weeks) of pre-nephrectomy
value. These findings confirmed earlier data of functional adap-
tation to uninephrectomy [5, 6, 11, 35]. The GFR in the
remaining normal kidney of humans is known to increase
promptly after contralateral nephrectomy [1]. Originally it was
thought that the increase was complete by seven days, but
recent work has shown that GFR continues to rise slightly three
to four months after the initial increment, although the delayed
improvement in function is small and inversely related to age
[35, 36].
Table 7. Data from PZA and PB tests in solitary kidneys with
GFR> 80 mI/mm (mean SD)
Group C
>1 year after
nephrectomy Controls(N=27) (N=21) P
PZA-suppressible urate 406 126 397 123 NS
,g/min
PZA-nonsuppressible 40 15 39 14 NS
urate ig/min
PZA-nonsuppressible 8.96 8.92 NS
uratc % of E,
Cur/Cc,. (FE0r) after 0.007 0.002 0.007 0.003 NS
PZA
Reabsorption of Fur 4533 1027 4672 1213 NS
/.Lg/Jnin
% Reabsorption of Fur 99.12 99.15 NS
Reabsorption of Sur 1552 545 1337 363 NS
/.Lg/min
% Reabsorption of Sur 79.26 77.23 NS
A FEur after P13 0.321 0.047 0.344 0.051 NS
Sur pg/min 1958 611 1731 425 NS
Symbols are: Eur, excreted urate; Fur, filtered urate; Sor, secreted
urate; A FEur, change of FEur.
With regards to tubular adaptation, our data showed a sharp
increase Of FEur which could not be attributed solely to the
increase in GFR of remaining kidney.
Groups
N
PZA-suppressible Ur /2g/lnin
PZA-nonsuppressible Ur pg/min
FEur after PZA
Reabsorption of Fur j.g/min
% Reabsorption of Fur
Reabsorption of Sor iLg1'mihl
A FEur after PB
Sur isg/min
P
g/min
P
p,g/min/
100 ml GFR
a b <0.001
a — b <0.001
a — b <0.001
a — b NS
a — b <0.01
Abbreviations are: Fur, filtered urate; Sur, secreted urate; FEur, Cur/Ccr; A FEur after PB, change of FEur after PB.
a Group A patients
b Group D patients
gImin/l00 ml GFR
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A B C D E
Fig. 1. Renalurate transport: (A) before unilateral nephrecto,ny, (B) 2 weeks, (C) 6 weeks and (D) 24 weeks after nephrectomy, (E) single kidney
patients with normal renal function and nephrectomized year(s) before, (A,) normal subject. Symbols are: (*) values per kidney, sgIml; (**) mean
value of a pair of kidneys; (***) from Fur.
The renal handling of urate can be conveniently rationalized
by a four-component sequential system: 1) filtration, 2) reab-
sorption, 3) secretion, and 4) post-secretory reabsorption.
Most, if not all, tubular transport is thought to occur in the
proximal tubule and perhaps the descending limb of the loop of
Henle [37, 38]. Hence, changes in urate clearance will reflect
proximal tubule function.
The response of urate excretion to drugs which alter renal
tubular transport of urate has been used to analyze the tubular
mechanisms of urate transport in humans by several authors
[22, 25, 26, 34, 39, 40]. However, internephron heterogeneity
and significant bi-directional transport of urate has been shown
to occur. Thus, urate transport in humans is more complex than
present techniques can analyze, and interpretation should be
considered to allow only tentative classification as to the most
likely defect [24]. In 1967, Steele and Rieselbach demonstrated
that in normal subjects oral administration of 3 g of PZA
profoundly inhibited urate secretion [27].
Studies of the effect of inhibition of urate reabsorption have
most often utilized PB.
In pre-operative studies, the PZA-nonsuppressible urate, that
is, the amount of filtered urate which escapes presecretory
reabsorption, was less than 1% of the filtered urate, suggesting
in almost complete presecretory reabsorption (99.39% of the
filtered urate). These data are consistent with previous studies
on normal subjects [22, 24—27, 39, 40]. After nephrectomy the
FEur following PZA administration and the PZA-nonsuppress-
ible urate were significantly higher. These findings indicating an
attenuated response to PZA strongly suggest a decreased reab-
sorption of filtered urate.
The presecretory urate reabsorption, expressed as a percent-
age of filtered urate, showed a sharp diminution. Thus, patients
reabsorbed only 93.86% of the filtered load.
When reabsorption of filtered urate is decreased, the re-
sponse to a uricosuric drug should be intact or increased.
Increased PZA-nonsuppressible associated with a relatively
increased PZA-suppressible urate excretion and decreased un-
cosuric response as seen in nephrectomized patients is compat-
ible with decreased reabsorption of both filtered and secreted
urate, according to Diamond's classification of various urico-
suric states [24].
In fact, when response to both PZA and PB is blunted
interpretation is unclear, since uricosunic response depends
upon intact secretion. When secretion remains constant atten-
uated response to PB strongly suggests a decreased reabsorp-
tion of secreted urate. The secreted urate from two kidneys
pre-operatively and from one kidney post-operatively (indirect-
ly estimated) is quite similar, although tubular urate secretion
cannot be accurately estimated. However, the estimation of the
secreted urate as proposed by Magoula and Garyfallos [22, 25,
39, 40] and applied in the present study should be more accurate
when compared to other studies [26], mainly in cases with
inhibition of presecretory reabsorption.
Although interpretations should allow only tentative classifi-
cation, the most likely defect in uricosuria seen after nephrec-
tomy is a diminished reabsorptive capacity for urate mainly at
the presecretory site.
Factors which might account for these changes of tubular
transport of urate are:
I) Rena/failure. Renal failure could affect changes in urate
transport, keeping in mind that CCr was significantly dimin-
ished. Garyfallos, Magoula and Tsapas [22] have reported an
impaired reabsorption of both filtered and secreted urate re-
sponsible for the increased urate excretion per nephron in CR1
(OCr = 30 to 70 mI/mm). In order to compare uninephrecto-
mized patients with acutely reduced GFR and single kidney
patients with CR1, we also studied 12 subjects 3 to 18 years after
kidney removal and with similar GFR. Patients with solitary
kidneys and CR1 showed a different pattern of urate excretion
with significantly lower Cur and FEur than the uninephrecto-
mized patients. Data from PZA and PB tests showed that
immediately after uninephrectomy PZA-suppressible and PZA-
nonsuppressible urate were significantly augmented, both as
absolute and per 100 mI/GFR values. Uricosuric response was
A1
(a) Presecretory reabsorption
(b) Tubular secretion
id Postsecretory reabsorption
Excreted 464
6.60%* 26.94%
"I,
99.15%
865*
77.23%
FEur 0.097 0.228
695 409 451 446 437**
8.80% 8.20%
0.097
9.19%
0.103
9.63%
0.098 0.093
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not different in the two groups. The findings suggest a dimin-
ished per nephron presecretory reabsorption and an augmented
per nephron tubular secretion in patients with acutely reduced
GFR. Concerning single kidney patients with CR1, our data
were similar with these of patients with a pair of kidneys and
about the same degree of renal insufficiency (Clr = 30 to 70
mt/mm) as reported by Garyfallos et al [22].
2) Urine flow rate. Urine flow rate may influence the Cur to a
small extent. Moreover, urate excretion returned to normal six
weeks after surgery while urine flow rate was constant.
3) pH. The urine pH should be checked and kept constant for
all studies (alkalinization enhances the response to PB). In our
studies the urine pH usually ranged between 5.0 and 6.0 and
never exceeded 7.0.
4) Sodium excretion. Our data showed a sharp increase in
fractional excretion of sodium, and the decreased proximal
reabsorption of sodium has been reported by many authors.
However, fractional sodium excretion returned to the pre-
operative values 10 days after uninephrectomy, while fractional
urate excretion still remained high. Moreover, fractional crate
excretion showed no correlation with fractional sodium excre-
tion.
5) Glucosuria. It is well known that urate reabsorption in the
proximal tubule is decreased in association with the develop-
ment of glucosuria [37, 39]. Our patients did not show gluco-
suria during the clearance period after surgery.
6) Extracellular volume. Uricosuria frequently indicates
extracellular fluid volume expansion [37], but cases presented
here showed no evidence of such a coexisting disorder.
7) Renal blood flow (RBF). The view that RBF is a major
determinant in urate excretion was first reported by Ferris and
Gorden [41], who showed that in normal subjects RBF and
urate excretion decreased during infusion of pressor doses of
angiotensin or norepinephrine, whereas GFR and osmolar
clearance did not change. Recently, a decline of urate clearance
during cyclosporin A treatment [42] and increased FE after
angiotensin converting enzyme inhibitor administration have
been reported [431.
Unilateral nephrectomy was followed by hyperperfusion and
hyperfiltration in the remaining kidney [35]. In donors the RBF
and GFR of the remaining kidney increased from half the
preoperative level to an average of 70 to 80% of the "two
kidney" performance [26, 271. Our findings showed that in-
creased RBF and GFR were not accompanied by an equal
capacity on the part of the proximal tubule to reabsorb urate
from the glomerular filtrate.
It is believed that the restoration of "glomerulotubular bal-
ance" necessitates hypertrophy and hyperplasia of tubule cells
[28], but little is known about the functional aspects of such
tubular changes concerning urate transport.
According to our findings, unilateral nephrectomy is followed
by important tubular transport modifications leading to a
marked uricosuria, which persisted after normalization of frac-
tional excretion of sodium and perhaps of glucose and proteins.
In our study tubular compensations were presumably com-
plete at six weeks, since pattern of tubular crate transport
returned to normal six weeks after uninephrectomy. Tubular
phases that modulate urate excretion in normal subjects as
reported by Puig et al [26] are: (a) almost complete reabsorption
at a site proximal to the tubular location of urate secretion
unrelated to filtered urate load; and (b) tubular secretion which
represents a 40% of filtered crate in normouricemic states with
a percentage of postsecretory reabsorption of 76.6%. Concern-
ing control subjects our findings were very similar to the above
described material. The pattern of renal urate transport in
solitary kidney with normal renal function also appeared to be
similar to those of a pair of kidneys. Thus, filtered urate
underwent almost complete reabsorption (99%) and therefore,
both tubular secretion and postsecretory reabsorption were
renal mechanisms for urate homeostasis. Secreted urate in
solitary kidneys significantly increased compared with 50% of
pre-uninephrectomy values, but the percentage of postsecre-
tory reabsorption remained quite constant and very close
(about 75 to 80%) to that seen in subjects with a pair of kidneys
(Fig. 1).
In summary, following uninephrectomy a marked uricosuria
occurs due to a diminished reabsorptive capacity for urate
mainly at the pre-secretory site. The adjustment in crate
excretion is achieved after six weeks and persists over years.
The pattern of renal tubular urate transport is similar to that of
a pair of kidneys. It is interesting that removal of one kidney
causes the fractional excretion of crate to increase in the
remaining organ sufficient to maintain crate balance with a
normal serum level in subjects with normal renal function.
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Appendix
PZA-nonsuppressible urate = minimum value of urate excretion after
PZA administration (this parameter represents a measure of filtered
urate which escapes presecretory reabsorption).
FEr (Cu,iCcr) after PZA = minimum value of FEur after PZA.
FEur (Cur/Ccr) after PB = maximum value of FEur after PB minus
FEur in the control period.
Presecretory reabsorption = filtered urate, (i.e., GFR x Pur) minus
PZA-nonsuppressible urate.
Postsecretory reabsorption or uricosuric response to PB = maximum
urate excretion after PB minus urate excretion in the control period.
PZA-suppressible urate = urateexcretion in the control period minus
PZA-nonsuppressible urate (this factor represents a measure of net
secretion," that is, the difference between secretion and postsecretory
reabsorption).
Secreted urate = excreted urate + postsecretory reabsorption minus
PZA-nonsuppressible urate because
and
excreted = (filtered — presecretory reabsorbed)
+ (secreted — postsecretory reabsorbed).
(filtered — presecretory reabsorbed) = PZA-nonsuppressible
therefore,
excreted = (PZA-nonsuppressible) + (secreted)
— (postsecretory reabsorbed).
The statistical analysis consisted of paired (for pre- and post-unine-
phrectomy values) and unpaired Student's 1-tests and P less than 0.01
was considered as significant. In the comparison of Group A patients
before and 2, 6, and 24 weeks after nephrectomy, the F-test was also
used.
